Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,220 INR | -0.71% | +0.75% | -16.79% |
Mar. 14 | India Ratings Keeps Balaji Amines Rating at AA; Outlook Stable | MT |
Jan. 31 | Balaji Amines Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- The company returns high margins, thereby supporting business profitability.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- With an expected P/E ratio at 35.79 and 24.44 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.79% | 870M | D+ | ||
+11.68% | 62.84B | A- | ||
-3.47% | 45.04B | A- | ||
+13.72% | 39.67B | B+ | ||
+17.83% | 25.73B | A- | ||
+7.27% | 18.27B | C+ | ||
-0.06% | 17.17B | B+ | ||
-21.73% | 15.81B | A- | ||
+0.22% | 14.96B | B+ | ||
-18.81% | 13.51B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BALAMINES Stock
- Ratings Balaji Amines Limited